Evidence map›Paper›PMID 42488428›Full record

ReviewFrontiers in cellular and infection microbiology2026

Natural and synthetic chemicals acting as enhancers of bacterial pathogenic success within the human host.

Maria Escobar-Salom, Isabel M Barceló, Elena Jordana-Lluch, Jordi Sansó-Sastre, Cristina Lasarte-Monterrubio, Alejandro Beceiro, Antonio Oliver, Carlos Juan

Abstract readReview
In one paragraph

Review in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Maria Escobar-Salom *Antibiotic Resistance and Pathogenicity of Bacterial Infections Research Group (ARPBIG) group, Health Research Institute of the Balearic Islands (IdISBa), Palma, Spain.
Isabel M Barceló *Antibiotic Resistance and Pathogenicity of Bacterial Infections Research Group (ARPBIG) group, Health Research Institute of the Balearic Islands (IdISBa), Palma, Spain.
Elena Jordana-LluchAntibiotic Resistance and Pathogenicity of Bacterial Infections Research Group (ARPBIG) group, Health Research Institute of the Balearic Islands (IdISBa), Palma, Spain.
Jordi Sansó-SastreAntibiotic Resistance and Pathogenicity of Bacterial Infections Research Group (ARPBIG) group, Health Research Institute of the Balearic Islands (IdISBa), Palma, Spain.
Cristina Lasarte-MonterrubioServicio de Microbiología and Instituto de Investigación Biomédica A Coruña (INIBIC), Complexo Hospitalario Universitario A Coruña (CHUAC), A Coruña, Spain.
Alejandro BeceiroCentro de Investigación Biomédica en Red, Área Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Antonio OliverAntibiotic Resistance and Pathogenicity of Bacterial Infections Research Group (ARPBIG) group, Health Research Institute of the Balearic Islands (IdISBa), Palma, Spain.
Carlos JuanAntibiotic Resistance and Pathogenicity of Bacterial Infections Research Group (ARPBIG) group, Health Research Institute of the Balearic Islands (IdISBa), Palma, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Like any other organism, bacteria are endowed with a myriad of receptors and signaling/regulatory mechanisms to detect chemical stimuli and develop appropriate responses. Whereas several of these chemicals - produced by bacteria themselves - display well-known effects in modulating their virulence-related performance (i.e. quorum sensing signals), many other substances not of microbial but different origin show an ability to influence bacterial behavior. The human organism poses the niche where pathogenic bacteria encounter some of these chemicals, since they are either produced naturally in the body (e.g. hormones, neurotransmitters, etc.) or are synthetic drugs/pollutants (sometimes called xenobiotics) to which people are frequently exposed at relevant doses mostly through inhalation or the diet. Alarmingly, several of these substances display effects that promote bacterial virulence, potentially having obvious negative consequences for the patient. In this scenario, this review integrates and discusses the most notorious data as to how different endogenous and synthetic compounds may impact bacteria biology within the human body context, finally improving their pathogenic success. Delving into this field is needed in order to emphasize the existence of chemicals to which exposure should be avoided as much as possible, and of some host/pathogen pathways that could be targeted so as to curb bacterial pathogenic power and thus alleviate the severity of certain infections.

Indexed as

BacteriaBacterial InfectionsHost-Pathogen InteractionsXenobioticsHumansQuorum SensingSignal TransductionVirulenceXenobioticsbiofilmendocrine disruptorshormonesinter-kingdom signalingmicrobial endocrinologyneurotransmitterspharmaceuticalsvirulence

Identifiers

PMID42488428
PMCPMC13388309

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.